Abstract Program

 

Abstract Program

The Scientific Program Committee invited authors to submit abstracts to be considered for inclusion in the scientific program. The submission of an abstract constitutes a formal commitment by the presenting author to present the abstract (if accepted) orally or as a poster in the session and the time assigned by the Scientific Program Committee. We therefore recommend that submitters of abstracts register for the congress simultaneously with abstract submission.

Abstract topics

  1. Acute lymphoblastic leukemia - Biology
  2. Acute lymphoblastic leukemia - Clinical
  3. Acute myeloid leukemia – Biology
  4. Acute myeloid leukemia – Clinical
  5. Chronic lymphocytic leukemia and related disorders - Biology
  6. Chronic lymphocytic leukemia and related disorders - Clinical
  7. Chronic myeloid leukemia – Biology
  8. Chronic myeloid leukemia – Clinical
  9. Hodgkin lymphoma – Biology
  10. Hodgkin lymphoma – Clinical
  11. MDS and bone marrow failure syndromes incl. PNH - Biology
  12. MDS and bone marrow failure syndromes incl. PNH - Clinical
  13. Myeloma and other monoclonal gammopathies – Biology
  14. Myeloma and other monoclonal gammopathies – Clinical
  15. Myeloproliferative disorders – Biology
  16. Myeloproliferative disorders – Clinical
  17. Non-Hodgkin lymphoma – Biology
  18. Non-Hodgkin lymphoma – Clinical
  19. Stem cell transplantation – Experimental
  20. Stem cell transplantation – Clinical
  21. Hematopoiesis, stem cells and microenvironment
  22. Signalling, transcription and apoptosis
  23. Cytogenetics and molecular diagnostics
  24. Drug resistance and pharmacology
  25. Genomics and proteomics
  26. Novel therapeutics, targeted therapies and gene therapy
  27. Cellular immunotherapy and vaccination
  28. Red blood cells and iron; physiology and disease (anemia) - Biology
  29. Red blood cells and iron; physiology and disease (anemia) - Clinical
  30. Infectious diseases, supportive care
  31. Transfusion medicine
  32. Granulocytes
  33. Platelets and thrombocytopenia
  34. Bleeding disorders (congenital and acquired)
  35. Thrombosis and vascular biology
  36. Quality of life, palliative care and ethics
  37. Health economics

 

This website uses cookies. By continuing to browse this website you are agreeing to our use of cookies.
Find out more by reading our General Terms & Conditions. Accept Cookies